NTC-121

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameNTC-121
Drug Alias NameNTC-121
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGnt Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGnt Pharma
Active IndicationsN/A
Inactive IndicationsGlioma

Other Information

ATC CodeN/A
Related LinksN/A